Recently treated patients (group 1) were invited to participate by a gynecologist or a nurse at the end of primary treatment, either while they were still hospitalized after surgery or after completing chemotherapy at the outpatient clinic, before attending follow-up. Patients who had attended more than 1 year of follow-up (group 2) were recruited in one of two ways: some were invited to participate during a follow-up visit to the gynecological outpatient clinic; others were identified in the hospitals' patient administrative system, and those who were alive and otherwise eligible received a written invitation to participate. Participation in the study had no consequence for the follow-up, and both patient groups attended the standard program provided by gynecologists at the hospital. All participating patients completed and signed an informed consent form.
| Data collection
All participating patients completed a questionnaire on their attitudes toward follow-up care. As we were unable to find an existing, suitable, validated questionnaire, a written questionnaire was developed by the research group (Appendix S1). Studies of cancer survivors', GPs' and gynecological oncologists' views on cancer follow-up were reviewed and relevant issues identified in the studies that were included. 1, 17, 18 We also included questions from our previous study investigating GPs' opinions on conducting follow-up visits for cancer patients, 5 in order to compare the opinions of the patients with those of GPs. The questionnaires were then piloted by a gynecologist and a nurse in an outpatient clinic, by three patients attending regular follow-up visits, and by six hospitalized patients recovering from primary treatment for gynecological cancer. The patients in the pilot study answered the questionnaire under the same conditions and in the same way as in the subsequent data collection. The final version was adjusted based on feedback from the pilot and collected demographic data, clinical data, expectations and attitudes toward follow-up in general, and attitudes toward the role of GPs in follow-up care
(Appendix S1). To evaluate patients' attitudes about specific aspects of follow-up care, we asked them to rate the given statements on a 4-point scale (from not important to very important).
The first 13 questions were identical for patients who had not 
Key Message
Gynecological cancer patients believed that detection of recurrence was the most important aspect of follow-up visits and preferred to be followed up by a gynecologist.
Patients who had not yet started follow-up were more willing to be followed up by a general practitioner.
| Statistical analyses
We used Chi-square tests to compare differences between patients who had not yet started follow-up and those who had attended more than 1 year of follow-up for categorical parameters. Multivariate logistic regression analysis was adjusted for age, comorbidity and cancer type. Associations are described as odds ratio (OR) with 95%
confidence interval (CI). We considered a P-value of <.05 to be statistically significant.
| Ethical approval
Ethical approval was obtained from The Regional Committee for 
| RE SULTS
In total, 239 gynecological cancer patients at three centers met the had attended more than 1 year of follow-up had at least one comorbid condition, the most common of which were cardiovascular and musculoskeletal disease (Table 1) .
| Attitudes toward follow-up by a general practitioner or gynecologist
Regardless of which patient group they were in, most patients were reluctant to be followed up by their GP (not yet started follow-up, 65%; attended more than 1 year of follow-up, 83%).
There was no significant difference between low-risk and highrisk patients in terms of willingness to be followed up by their GP (26% vs. 22%, P = .77). Among patients with at least one comorbid condition, 28% were willing to be followed up by a GP under certain conditions (good cooperation between GP and hospital, quick re-referral back to gynecologist when needed or shared responsibility between GP and gynecologist), compared with 17%
of those without any comorbidity, irrespective of cancer type.
However, this difference was not statistically significant. In multivariate analysis, those who had not yet started follow-up were three times more willing to be followed up by a GP, either alone or under certain conditions (see above), as compared with those who had attended more than 1 year of follow-up (OR 3.0, 95% CI 1.59 to 5.59, P = .001). A majority of the 239 participating patients preferred to discuss issues regarding cancer and its consequences with a gynecologist rather than with their GP (P < .001), the only exception was economical issue (Figure 1) . In the open field where patients could give the reasons for their preferences, they cited specific competence as the main reason for preferring follow-up by gynecologists (Table 2) .
| Attitudes toward content of follow-up
The majority of patients who had not yet started follow-up (61%)
expected to be followed up every 3 months for 5 years, which corresponds well with the present follow-up guidelines. 16 Patients rated every aspect of the follow-up visit as important, and the responses did not differ between those who had not yet started follow-up and those who had attended more than 1 year of follow-up ( Figure 2 ). "Detection of recurrence" was rated "very important" by 93% of the total study sample, whereas "follow-up of late effects after treatment" was nearly three times more important to patients under the age of 50 years (n = 44) than to patients who were over 50 years of age (n = 193) (OR 2.7, 95% CI 1.06 to 6.99, P = .04).
Regarding what made them feel confident during follow-up visits, the statement "that the physician knows me" was rated as most important by 75% of the study sample, whereas the statement "that the doctor shows interest in me as a person" was rated was more important to endometrial and cervical cancer patients than to ovarian and vulvar cancer patients (P = .044), whereas blood tests were significantly more important to ovarian cancer patients than to patients with other types of gynecological cancer (P = .009).
Most patients who had attended follow-up for more than 1 year (89%) felt that the current follow-up model responded to their expectations to a great/very great extent. When asked to suggest changes that could improve follow-up, the most frequent suggestion was "meeting the same physician each time" (17%).
| D ISCUSS I ON
Gynecological cancer patients preferred to be followed up by gynecologists rather than by their GP, whom they viewed as less competent for this purpose. However, patients who had not yet started follow-up were more willing to be followed up by a GP, provided there was good cooperation between the GP and the hospital, compared with patients who had attended more than 1 year of followup. Overall, detection of recurrence was rated as the most important aspect of the follow-up visit. Undergoing a gynecological examination and being met by a doctor who shows interest in them as a person were more important to cancer patients who had attended more than 1 year of follow-up than to those who had not yet started follow-up.
Our results are in line with findings of previous studies regarding patients' follow-up preferences. 9, 14, 15, [18] [19] [20] [21] However, those studies were conducted among patients who were already being followed up by specialists. To our knowledge, this is the first study to compare views on follow-up care between patients with and without experience from a follow-up regimen. Discrepancies in My GP is easily accessible 5
Why would you not like to be followed up by your GP ?a
Gynecologists are specialists 70
My GP does not have ultrasound 8
The gynecologist has more experience 6
I feel more confident when I am being followed up by a gynecologist.
I do not have confidence in my GP 6
I have a male GP 2 a Some answers are categorized because of similarity.
F I G U R E 2 How important are these aspects of a follow-up visit? (n = 239) attitudes between our patient groups may be explained by the lack of experience and prejudices on the part of patients who had not started follow-up.
The preference of being followed up by a specialist and not a GP seems to be determined by emotions and expectations rather than by risk of recurrence, as even low-risk patients preferred hospital specialist follow-up. The preference of a specialist may also be founded on a belief that GPs have limited abilities to perform cancer-specific follow-up care. [12] [13] [14] 21, 22 However, according to previous studies, not only do GPs feel competent to provide this kind of follow-up care, they regard themselves as better suited than specialists to provide psychosocial support to cancer patients. 5, 23 Contrary to our findings, cross-sectional studies of patients with breast, prostate and melanoma cancer have shown that these patients prefer to see their GP for psychosocial matters and general care. 13, 24, 25 The patients in our study thought that the main reason for attending follow-up is to detect possible recurrence, which is in line with most previous studies. 18, 22 However, it has been shown that recurrent gynecological cancer is often detected by the patient herself between scheduled visits because of symptoms. 8 Thus, many patients seem to have an unrealistic view of the importance of gynecological examination, which overshadowed the other aspects of follow-up in our study (such as psychosocial support, follow-up of late effects after treatment and getting information about the disease).
According to a systematic review regarding models of follow-up care for patients with breast, colon, lung and prostate cancer, follow-up provided by GPs is equivalent to follow-up provided by specialists in regard to detecting recurrence. 26 The preference of follow-up by specialists in our study could indicate that this knowledge has not been passed on to patients. Indeed, a systematic review 27 showed that cancer patients are not well informed about the lack of effectiveness of examinations and tests, and therefore are not aware of the limitations of hospital-based routine follow-up.
We expected patients with comorbid conditions to be more willing to be followed up by their GP, due to their relationship and regular appointments with them; however, we did not find any such significant correlation. This differs from a study by Nyarko et al, 12 which showed that cancer patients (with several cancer types) who visited their GP frequently rated follow-up by a GP significantly higher than did patients who visited their GP less often.
Previous studies on cancer patients already attending follow-up have shown that most patients prefer to continue their current frequency of visits, 11, 17, 22 which confirms the tendency of patients to favor the existing service. 11 Guidelines available on the internet or information given before the end of treatment may influence patients' expectations even before they enter the follow-up program. Regarding desired duration of follow-up, one study showed that more than half of the surveyed patients preferred a longer follow-up period than that recommended, even up to the end of their lives, because of fear of recurrence. 20 This shows that the patients find follow-up reassuring in terms of detecting recurrence and indicates that they expect a better outcome through lifelong follow-up.
Age seemed to influence patients' views on the importance of different aspects of follow-up visits, as younger patients (<50 years) rated "follow-up of late effects after treatment" as significantly more important compared with older patients. This could be explained by the expectation of younger patients that they will live longer while suffering from late effects, and perhaps more expectations regarding varying aspects of quality of life. We found no previous studies investigating this topic.
Provider continuity in follow-up care seems to be important, as the statement "that the physician knows me" was the most important aspect in terms of making the patients feel confident in the follow-up visit. This corresponds well with the desire of the patients who had attended more than 1 year of follow-up to meet the same physician at each follow-up visit. The importance of provider continuity was also shown in a systematic review 28 which concluded that increased provider continuity is associated with improved patient outcome and satisfaction. However, meeting the same physician each time is somewhat contradictory to the preference for being followed up by a gynecologist, as lack of continuity is a well-known problem in hospital follow-up.
F I G U R E 3
What makes you feel confident in the follow-up visit? (n = 239)
